Ho Young Huh
Chairman chez PLIANT THERAPEUTICS, INC.
Fortune : 5 M $ au 31/03/2024
Profil
Ho Young Huh is the founder of Konus Advisory Group, Inc. (founded in 2012) where he served as the Managing Director from 2012 to 2014.
He is also the founder of StemPar Sciences, Inc. (founded in 2012) and holds the title of Chairman.
Additionally, Dr. Huh founded Rezolute, Inc. (founded in 2010) and served as the Vice Chairman from 2018 to 2019.
He also founded pH Pharma Co., Ltd.
(founded in 2015) and held the title of Chairman & Co-Chief Executive Officer.
Dr. Huh is also the founder of Healthcare & Humanity Foundation.
Dr. Huh's current job(s) include being the Chief Executive Officer at Peak Bio Co. Ltd., Chairman at Pliant Therapeutics, Inc., Chairman at Peak Bio, Inc. (since 2022), and Director at SciDose LLC, Interplast, SFJAZZ, and Resurge International.
His former job(s) include being the Chairman, President & Chief Executive Officer at BiPar Sciences, Inc. from 2008 to 2011, Chairman at Geron Corp.
from 2010 to 2018, Chairman at CytomX Therapeutics Holdings LLC, Chairman at CytomX Therapeutics, Inc. from 2011 to 2018, Chairman at Epizyme, Inc. from 2009 to 2012, Director at Nektar Therapeutics in 2009, Director at Calibra Medical LLC, Director at Abbott Biotherapeutics Corp.
from 2009 to 2010, Non-Executive Director at Addex Therapeutics Ltd.
from 2011 to 2014, Director at The Bay Area Bioscience Association, Independent Director at EOS SpA, Director at Synchronicity Pharma, Inc., Director at Bionik Laboratories Corp., Director at 4D Molecular Therapeutics, Inc., Director at Ascendancy Healthcare, Inc., Director at Eidos Therapeutics, Inc., Partner at McKinsey & Co., Inc., and Managing Partner at Quintessa Investment Co. Ltd.Dr. Huh's education includes an undergraduate degree from Dartmouth College and a doctorate degree from Weill Cornell Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/06/2023 | 239 619 ( 0,40% ) | 4 M $ | 31/03/2024 | |
PEAK BIO, INC.
39,97% | 21/09/2023 | 8 755 682 ( 39,97% ) | 2 M $ | 31/12/2023 |
Postes actifs de Ho Young Huh
| Sociétés | Poste | Début |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Chairman | 01/05/2018 |
| PEAK BIO, INC. | Chairman | 01/11/2022 |
Peak Bio Co. Ltd.
 Peak Bio Co. Ltd. BiotechnologyHealth Technology Part of Peak Bio, Inc., Peak Bio Co. Ltd. is a South Korean clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and inflammation. Peak Bio's location is in Seongnam, South Korea. The private company's lead product candidate, php-303, is a small molecule currently in phase II clinical study for the orphan disease alpha1 anti-trypsin deficiency. Peak Bio has successfully completed phase I trials, demonstrating dose-dependent pharmacokinetics and establishing a dose for upcoming clinical trials. The company's cancer platform includes novel payloads and antibody-drug-conjugates (ADC) to address unmet needs in cancer care. The company was founded in 2015, and the CEO is Ho Young Huh. Peak Bio Co. was acquired by Ignyte Acquisition Corp. on November 01, 2022 for $353.84 million. | Chief Executive Officer | - |
Resurge International
 Resurge International Medical/Nursing ServicesHealth Services Resurge International operates surgical care facilities for poor children and adults. | Director/Board Member | - |
| SFJAZZ | Director/Board Member | - |
StemPar Sciences, Inc.
 StemPar Sciences, Inc. Medical/Nursing ServicesHealth Services StemPar Sciences, Inc. develops cancer drugs treatments. It provides cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy/radiation induced DNA damage. The company was founded by Hoyoung Huh and Mircea Florin Mihaescu in 2012 and is headquartered in Mill Valley, CA. | Founder | 01/01/2012 |
Interplast
 Interplast Hospital/Nursing ManagementHealth Services Interplast is a group of individuals founded by Dr. Laub from Stanford University who are concerned with the maldistribution of medicine. Interplast is based in Sunnyvale, CA. The non-profit company provides direct care to people who do not have access to surgery and educate professionals. The group has inspired thousands of international humanitarian trips around the world by many surgeons who are motivated to change lives through plastic and reconstructive surgery. | Director/Board Member | 19/04/2011 |
| SciDose LLC | Director/Board Member | 19/04/2011 |
Anciens postes connus de Ho Young Huh
| Sociétés | Poste | Fin |
|---|---|---|
| REZOLUTE, INC. | Founder | 10/02/2019 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Ho Young Huh
| Dartmouth College | Undergraduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 9 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| GERON CORPORATION | Health Technology |
| ADDEX THERAPEUTICS LTD | Health Technology |
| REZOLUTE, INC. | Health Technology |
| BIONIK LABORATORIES CORP. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| PEAK BIO, INC. | Health Technology |
| Entreprise privées | 21 |
|---|---|
BiPar Sciences, Inc.
 BiPar Sciences, Inc. Pharmaceuticals: MajorHealth Technology BiPar Sciences, Inc. develops and markets drugs for cancer patients. It offers BSI-201, a poly ADP-ribose polymerase (PARP) inhibitor for metastatic triple negative breast cancer, ovarian cancer, and other malignancies; BSI-401, a follow-on PARP inhibitor candidate for pancreatic cancer; and BSI-301, an iodothyronine program with anti-tubulin properties. The company was founded by Barry M. Sherman, Thomas F. White and Allan Basbaum in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
Calibra Medical LLC
 Calibra Medical LLC Medical SpecialtiesHealth Technology Calibra Medical LLC develops and markets medical devices and technologies in the diabetes sector. Its products include finesse and insulin delivery devices. The company was founded by Daniel Hawkins and Clifton A. Alferness in 2004 and is headquartered in Wayne, PA. | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
Konus Advisory Group, Inc.
 Konus Advisory Group, Inc. Investment ManagersFinance Konus Advisory Group, Inc. operated as a boutique advisory firm. It served the healthcare industries in markets including Asia, Latin America, and the Middle East. The firm provided targeted consulting to select clients as they navigate new geographies, advising both the United States and European organizations. The company was founded by Michael Masterson, Nevan Charles Elam and Hoyoung Huh in 2012 and was headquartered in Menlo Park, CA. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
| The Bay Area Bioscience Association | Health Technology |
| SciDose LLC | |
EOS SpA
 EOS SpA Pharmaceuticals: MajorHealth Technology EOS SpA engages in the manufacture of biopharmaceutical products. The company was founded by Silvano Spinelli, Gabriella Camboni, Ennio Cavalletti and Jacques Theurillat in June 2006 and is headquartered in Milan, Italy. | Health Technology |
Interplast
Interplast Hospital/Nursing ManagementHealth Services Interplast is a group of individuals founded by Dr. Laub from Stanford University who are concerned with the maldistribution of medicine. Interplast is based in Sunnyvale, CA. The non-profit company provides direct care to people who do not have access to surgery and educate professionals. The group has inspired thousands of international humanitarian trips around the world by many surgeons who are motivated to change lives through plastic and reconstructive surgery. | Health Services |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Health Technology |
StemPar Sciences, Inc.
StemPar Sciences, Inc. Medical/Nursing ServicesHealth Services StemPar Sciences, Inc. develops cancer drugs treatments. It provides cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy/radiation induced DNA damage. The company was founded by Hoyoung Huh and Mircea Florin Mihaescu in 2012 and is headquartered in Mill Valley, CA. | Health Services |
Resurge International
Resurge International Medical/Nursing ServicesHealth Services Resurge International operates surgical care facilities for poor children and adults. | Health Services |
Ascendancy Healthcare, Inc.
 Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Health Technology |
Quintessa Investment Co. Ltd.
 Quintessa Investment Co. Ltd. Investment ManagersFinance Quintessa Investment acts as alternative investment manager. It is engaged in financial investment activities. The company was founded on January 13, 2011 and is headquartered in Seoul, South Korea. | Finance |
pH Pharma Co., Ltd.
 pH Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology pH Pharma Co. Ltd. engages in the developing and manufacturing of bio-pharmaceuticals. Its products include php-303, php-201, ab-101, nuvesse, alpine and torpedo products. The company was founded by Ho Young Huh on September 22, 2015 and is headquartered in Seoul, South Korea. | Health Technology |
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
| Healthcare & Humanity Foundation | |
Peak Bio Co. Ltd.
Peak Bio Co. Ltd. BiotechnologyHealth Technology Part of Peak Bio, Inc., Peak Bio Co. Ltd. is a South Korean clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and inflammation. Peak Bio's location is in Seongnam, South Korea. The private company's lead product candidate, php-303, is a small molecule currently in phase II clinical study for the orphan disease alpha1 anti-trypsin deficiency. Peak Bio has successfully completed phase I trials, demonstrating dose-dependent pharmacokinetics and establishing a dose for upcoming clinical trials. The company's cancer platform includes novel payloads and antibody-drug-conjugates (ADC) to address unmet needs in cancer care. The company was founded in 2015, and the CEO is Ho Young Huh. Peak Bio Co. was acquired by Ignyte Acquisition Corp. on November 01, 2022 for $353.84 million. | Health Technology |
| SFJAZZ |
